Dong-A Pharm launches liquid-type human growth hormone grotropin-II injection

Published: 2003-12-10 06:59:00

Updated: 2003-12-10 06:59:00

Dong-A Pharm announced it has launched a liquid-type human growth hormone grotropin-II injection based on the EP standards for the first time in Korea after successful development of its formulation process in April 1999 via stability tests in July 1996.

According to the company's officials, the Korea Food and Drug Administration approved the liquid-type grotropin-II injection on July of the...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.